Esther, Charles R.

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A., & Noone, P. G. (2010) · Journal of Cystic Fibrosis

Mycobacterium research and diagnosisCystic Fibrosis Research Advances

Cited by 410

Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis

Cholon, D. M., Quinney, N. L., Fulcher, M. L., Esther, C. R., Das, J., Dokholyan, N. V., Randell, S. H., Boucher, R. C., & Gentzsch, M. (2014) · Science Translational Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 320

Lung transplant outcomes in cystic fibrosis patients with pre‐operative Mycobacterium abscessus respiratory infections

Lobo, L. J., Chang, L. C., Esther, C. R., Gilligan, P. H., Tulu, Z., & Noone, P. G. (2013) · Clinical Transplantation

Mycobacterium research and diagnosisTransplantation: Methods and Outcomes

Cited by 108

Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy

Guimbellot, J. S., Ryan, K. J., Anderson, J. D., Liu, Z., Kersh, L., Esther, C. R., Rowe, S. M., & Acosta, E. P. (2020) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesPharmacogenetics and Drug Metabolism

Cited by 24